Insider: Watts Ryan J. President and CEO - Denali Therapeutics Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 296,833 | 2,268,363 | 2,565,196 |
| Value | $5,841,673.44 | $44,641,383.84 | $50,483,057.28 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 01/06/2026 | DDS | 35,198 | Direct | COM | $16.50 | $580,767.00 | 296,833 |
| 07/09/2025 | DDS | 495,282 | Direct | COM | $15.00 | $7,429,230.00 | 253,071 |
| 01/07/2025 | DDS | 7,650 | Direct | COM | $20.81 | $159,196.50 | 253,071 |
| 01/06/2025 | DDS | 29,266 | Direct | COM | $20.22 | $591,758.52 | 260,721 |
| 10/18/2024 | DDS | 40,000 | Direct | COM | $27.69 | $1,107,600.00 | 235,807 |
| 08/20/2024 | DDS | 2,260 | Direct | COM | $23.79 | $53,765.40 | 235,807 |
| 02/13/2024 | DDS | 9,589 | Direct | COM | $17.29 | $165,793.81 | 238,067 |
| 01/09/2024 | DDS | 7,818 | Indirect | COM | $19.78 | $154,640.04 | 2,268,363 |
| 01/05/2024 | DDS | 17,483 | Indirect | COM | $19.43 | $339,694.69 | 2,276,181 |
| 08/21/2023 | DDS | 2,309 | Indirect | COM | $22.59 | $52,160.31 | 2,242,604 |
| 08/10/2023 | DDS | 2,526 | Indirect | COM | $25.03 | $63,225.78 | 2,239,913 |
| 04/21/2023 | DDS | 24,800 | Indirect | COM | $25.15 | $623,720.00 | 2,239,913 |
| 04/20/2023 | DDS | 200 | Indirect | COM | $25.00 | $5,000.00 | 2,239,913 |
| 02/13/2023 | DDS | 8,815 | Indirect | COM | $30.09 | $265,243.35 | 2,239,913 |
| 02/13/2023 | DDS | 25,000 | Indirect | COM | $30.08 | $752,000.00 | 2,239,913 |
| 01/05/2023 | DDS | 4,800 | Indirect | COM | $28.44 | $136,512.00 | 2,223,664 |
| 01/04/2023 | DDS | 5,029 | Indirect | COM | $28.73 | $144,483.17 | 2,213,464 |
| 08/19/2022 | DDS | 2,404 | Indirect | COM | $33.22 | $79,860.88 | 2,202,993 |
| 02/11/2022 | DDS | 9,491 | Indirect | COM | $34.72 | $329,527.52 | 2,129,648 |
| 02/09/2022 | DDS | 2,719 | Indirect | COM | $37.55 | $102,103.62 | 2,119,442 |
| 01/05/2022 | DDS | 5,007 | Indirect | COM | $44.78 | $224,213.46 | 2,113,361 |
| 12/01/2021 | DDS | 805 | Indirect | COM | $46.35 | $37,311.75 | 2,103,368 |
| 12/01/2021 | DDS | 8,516 | Indirect | COM | $44.39 | $378,025.24 | 2,113,185 |
| 12/01/2021 | DDS | 9,012 | Indirect | COM | $45.30 | $408,243.60 | 2,104,173 |
| 11/01/2021 | DDS | 1,659 | Indirect | COM | $48.61 | $80,643.99 | 2,138,375 |
| 1 2 3 4 5 Next Last You are at page 1 of 5 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research